Interneuron Diversity series: Rhythm and mood in perisomatic inhibition

Trends in Neurosciences

Volumn 26, Issue 9, 2003, Pages 489-495

  Freund, Tamás F ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM BINDING PROTEIN; CALRETININ; CANNABINOID; CANNABINOID RECEPTOR; CHOLECYSTOKININ; GABAERGIC RECEPTOR AFFECTING AGENT; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER; NICOTINIC AGENT; PARVALBUMIN; PRESYNAPTIC RECEPTOR; SEROTONIN ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACTION POTENTIAL; ANXIETY DISORDER; BASKET CELL; BRAIN CORTEX; CELL; CELL FUNCTION; CELL POPULATION; CELL SYNCHRONIZATION; CELL TYPE; COGNITION; DENDRITE; DRUG EFFECT; ELECTROPHYSIOLOGY; EMOTION; GAMMA RHYTHM; HIPPOCAMPUS; HYPOTHESIS; INNERVATION; INTERNEURON; MOLECULAR CLOCK; MOLECULAR MECHANICS; MOOD; MOOD DISORDER; MOTIVATION; NERVE CELL NETWORK; NERVE FIBER; NONHUMAN; OSCILLATION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REVIEW; RHYTHM; SENSORY NERVE; SIGNAL TRANSDUCTION; SYNAPSE; SYNCYTIUM; THETA RHYTHM; TRANQUILIZING ACTIVITY;

EID: 0041423730     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(03)00227-3     Document Type: Review

References (70)

1. Somogyi P., et al. Salient features of synaptic organisation in the cerebral cortex. Brain Res. Brain Res. Rev. 26:1998;113-135.
2. Gulyás A.I., et al. Hippocampal pyramidal cells excite inhibitory neurons through a single release site. Nature. 366:1993;683-687.
3. Buhl E.H., et al. Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature. 368:1994;823-828.
4. Klausberger T., et al. Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature. 421:2003;844-848.
5. Miles R., et al. Differences between somatic and dendritic inhibition in the hippocampus. Neuron. 16:1996;815-823.
6. Bragin A., et al. Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat. J. Neurosci. 15:1995;47-60.
7. Cobb S.R., et al. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature. 378:1995;75-78.
8. Freund T.F., Buzsáki G. Interneurons of the hippocampus. Hippocampus. 6:1996;347-470.
9. Buzsáki G., Chrobak J.J. Temporal structure in spatially organized neuronal ensembles: a role for interneuronal networks. Curr. Opin. Neurobiol. 5:1995;504-510.
10. Gray C.M. Synchronous oscillations in neuronal systems: mechanisms and functions. J. Comput. Neurosci. 1:1994;11-38.
11. Singer W. Consciousness and the binding problem. Ann. N. Y. Acad. Sci. 929:2001;123-146.
12. Traub R.D., et al. Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity. Prog. Neurobiol. 55:1998;563-575.
13. Somogyi P. A specific 'axo-axonal' interneuron in the visual cortex of the rat. Brain Res. 136:1977;345-350.
14. 2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res. 419:1987;119-130.
15. Acsády L., et al. Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in rat hippocampus. Neuroscience. 73:1996;299-315.
16. Nunzi M.G., et al. Cholecystokinin-immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus. J. Comp. Neurol. 237:1985;485-505.
17. Cauli B., et al. Molecular and physiological diversity of cortical nonpyramidal cells. J. Neurosci. 17:1997;3894-3906.
18. Thomson A.M., et al. Differential sensitivity to Zolpidem of IPSPs activated by morphologically identified CA1 interneurons in slices of rat hippocampus. Eur. J. Neurosci. 12:2000;425-436.
19. Maccaferri G., et al. Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurones in rat hippocampus in vitro. J. Physiol. 524:2000;91-116.
20. Pawelzik H., et al. Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus. J. Comp. Neurol. 443:2002;346-367.
21. Wilson R.I., et al. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron. 31:2001;453-462.
22. Vreugdenhil M., et al. Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J. Neurophysiol. 89:2003;1414-1422.
23. Tamás G., et al. Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons. Nat. Neurosci. 3:2000;366-371.
24. Traub R.D., et al. Gap junctions between interneuron dendrites can enhance synchrony of gamma oscillations in distributed networks. J. Neurosci. 21:2001;9478-9486.
25. Galarreta M., Hestrin S. A network of fast-spiking cells in the neocortex connected by electrical synapses. Nature. 402:1999;72-75.
26. Gibson J.R., et al. Two networks of electrically coupled inhibitory neurons in neocortex. Nature. 402:1999;75-79.
27. Meyer, A.H. et al. (2002) An electrically coupled hippocampal network of cholecystokinin (CCK)-positive GABAergic interneurons revealed by transgenic mice expressing green fluorescent protein in CCK-positive neurons. Program No. 836.2. 2002 Abstract Viewer and Itinerary Planner, Society for Neuroscience, Online.
28. Amitai Y., et al. The spatial dimensions of electrically coupled networks of interneurons in the neocortex. J. Neurosci. 22:2002;4142-4152.
29. Meyer A.H., et al. In vivo labeling of parvalbumin-positive interneurons and analysis of electrical coupling in identified neurons. J. Neurosci. 22:2002;7055-7064.
30. Low K., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 290:2000;131-134.
31. A receptors in synapses of hippocampal pyramidal cells of the rat. Eur. J. Neurosci. 13:2001;428-442.
32. Klausberger T., et al. Cell type- and input-specific differences in the number and subtypes of synaptic GABA(A) receptors in the hippocampus. J. Neurosci. 22:2002;2513-2521.
33. Ravard S., Dourish C.T. Cholecystokinin and anxiety. Trends Pharmacol. Sci. 11:1990;271-273.
34. Vallebuona F., et al. Release of cholecystokinin-like immunoreactivity in the frontal cortex of conscious rats as assessed by transcerebral microdialysis: effects of different depolarizing stimuli. J. Neurochem. 61:1993;490-495.
35. Fabre L.F., McLendon D. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. J. Clin. Pharmacol. 21:1981;377S-382S.
36. Haller J., et al. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur. J. Neurosci. 16:2002;1395-1398.
37. Sethi B.B., et al. Antianxiety effect of cannabis: involvement of central benzodiazepine receptors. Biol. Psychiatry. 21:1986;3-10.
38. Katona I., et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19:1999;4544-4558.
39. Katona I., et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21:2001;9506-9518.
40. Bodor A., et al. Cellular and subcellular localization of CB1 cannabinoid receptor in rat somatosensory cortex. FENS Meeting 2002, Paris. 2002.
41. Hájos N., et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12:2000;3239-3249.
42. Beinfeld M.C., Connolly K. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci. Lett. 301:2001;69-71.
43. A responses in hippocampal pyramidal cells. J. Neurosci. 12:1992;4122-4132.
44. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 410:2001;588-592.
45. B (R1) receptors in the rat hippocampus by immunocytochemistry and high resolution autoradiography, with specific reference to its localization in identified hippocampal interneuron subpopulations. Neuropharmacology. 38:1999;1707-1721.
46. B autoreceptors in rat hippocampus. J. Physiol. 472:1993;245-265.
47. 3 receptors. Pharmacol. Ther. 47:1990;181-202.
48. 3-receptor antagonist. Br. J. Pharmacol. 93:1988;985-993.
49. 3 receptor mRNA. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1430-1434.
50. Morales M., Bloom F.E. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J. Neurosci. 17:1997;3157-3167.
51. 3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/ cholecystokinin interneurons. J. Neurosci. 22:2002;7389-7397.
52. Freund T.F., et al. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc. Natl. Acad. Sci. U. S. A. 87:1990;8501-8505.
53. Papp E.C., et al. Medial septal and median raphe innervation of vasoactive intestinal polypeptide-containing interneurons in the hippocampus. Neuroscience. 90:1999;369-382.
54. File S.E., et al. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav. Neurosci. 112:1998;1423-1429.
55. Irvine E.E., et al. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol. Biochem. Behav. 68:2001;319-325.
56. Freedman R., et al. α-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J. Neurosci. 13:1993;1965-1975.
57. Frazier C.J., et al. Acetylcholine activates an α-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J. Neurosci. 18:1998;1187-1195.
58. Porter J.T., et al. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J. Neurosci. 19:1999;5228-5235.
59. Hájos N., et al. Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience. 82:1998;355-376.
60. Gulyás A.I., et al. Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J. Neurosci. 19:1999;10082-10097.
61. Matyas F., et al. Estimation of the total number of excitatory and inhibitory synaptic inputs onto rat hippocampus CA1 area CCK-containing basket cells, a light and electron microscopical study. FENS Meeting 2002, Paris. 2002.
62. Nyiri G., et al. Large variability in synaptic NMDA receptor density on interneurons and a comparison with pyramidal cell spines in the rat hippocampus. Neuroscience. 119:2003;347-363.
63. Gulyás A.I., et al. Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J. Neurosci. 16:1996;3397-3411.
64. Gray J.A. Precis of the neuropsychology of anxiety: an inquiry into the functions of the septo-hippocampal system. Behav. Brain Sci. 5:1982;469-534.
65. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15:1992;353-375.
66. File S.E., et al. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66:2000;65-72.
67. Larsson L.I., Rehfeld J.F. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res. 165:1979;201-218.
68. Herkenham M., et al. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1932-1936.
69. Cope D.W., et al. Cholecystokinin-immunopositive basket and Schaffer collateral- associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience. 109:2002;63-80.
70. McBain C.J., et al. Glutamatergic synapses onto hippocampal interneurons: precision timing without lasting plasticity. Trends Neurosci. 22:1999;228-235.